logo
Patients in transition
HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype
CD4+CD73+ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression
The γδ T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction
Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort
Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine
Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma
Polymorphisms in the interleukin-7 receptor α gene and mortality in untreated HIV-infected individuals
Relationship between mortality and feeding modality among children born to HIV-infected mothers in a research setting
The contribution of HIV to pregnancy-related mortality
Insurability of HIV-positive people treated with antiretroviral therapy in Europe
Grassroots community organizations’ contribution to the scale-up of HIV testing and counselling services in Zimbabwe
Towards a better understanding of Kaposi sarcoma-associated immune reconstitution inflammatory syndrome
Transmitted drug resistance in French HIV-2-infected patients
The effect of antiretrovirals on Plasmodium falciparum liver stages
Test performance of beta-glucan for Pneumocystis jirovecii pneumonia put in a clinical context
Human serum increases CD4 recycling to plasma membranes of in-vitro cultured cells
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients
Safety of abacavir therapy after temporary interruptions in patients without hypersensitivity reactions to the drug